Astrazeneca PLC (NYSE:AZN)’s share price gapped down before the market opened on Monday . The stock had previously closed at $32.33, but opened at $32.60. Astrazeneca PLC shares last traded at $33.31, with a volume of 3,646,800 shares changing hands.

AZN has been the topic of several recent analyst reports. Shore Capital reaffirmed a “hold” rating on shares of Astrazeneca PLC in a report on Wednesday, July 27th. Bank of America Corp. reissued a “buy” rating and issued a $36.65 price target on shares of Astrazeneca PLC in a research note on Monday, July 18th. Citigroup Inc. reissued a “buy” rating on shares of Astrazeneca PLC in a research note on Saturday, June 25th. Beaufort Securities reissued a “hold” rating on shares of Astrazeneca PLC in a research note on Friday, August 26th. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of Astrazeneca PLC in a research note on Thursday, July 28th. Two analysts have rated the stock with a sell rating, eight have given a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $36.88.

The stock has a 50-day moving average price of $32.95 and a 200 day moving average price of $30.09. The stock has a market capitalization of $84.27 billion and a P/E ratio of 38.07.

Astrazeneca PLC (NYSE:AZN) last released its earnings results on Thursday, July 28th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.07. The firm earned $5.60 billion during the quarter, compared to analysts’ expectations of $5.56 billion. Astrazeneca PLC’s revenue for the quarter was down 4.0% on a year-over-year basis. During the same quarter last year, the company posted $1.21 earnings per share. Analysts forecast that Astrazeneca PLC will post $2.97 EPS for the current fiscal year.

The company also recently announced a dividend, which will be paid on Monday, September 12th. Shareholders of record on Friday, August 12th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Wednesday, August 10th.

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.